Alternatives to Shapely

It prices Ozempic and Zepbound at $1,399 and $1,599, which almost nobody here does. The compounded line is “from” $49 — under a dated sale, and billed every four weeks.

The brand-access marketplace: real FDA-approved pens and oral options with insurance-style navigation — but a required video visit, a 28-day billing cycle, and prices that sit well above the compounded field.

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

A high-volume general telehealth platform, not a GLP-1 specialist — $99 flat for a one-time doctor consultation with no membership, but the medication cost is billed separately and never itemized, so the real monthly total is unknown until you fill the prescription.

AskRx solves the pricing question most of this page leaves open, and creates a different one. Its care fee is itemized in its own footnote — $90/month physician visit, $10/month fulfilment, $100 total — and the medication is billed separately through its own pharmacy, at cost, with both halves shown at checkout. If you have ever wondered how much of a blended monthly price is the drug and how much is margin, this is the provider that answers it. It is FDA-approved only ('No compounded meds'), so the options are the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the oral tirzepatide. All 50 states, board-certified physicians with obesity-medicine training, unlimited messaging, monthly titration, cancel anytime. Two logistics notes that matter on a workday. First, $100 is a floor: no medication price is published, so your real monthly total is unknown until checkout and depends on coverage. Second — and read this one if scheduling is your constraint — 'video visits available in select states' means the async route is not universal here, so confirm your own state before assuming you can do this without a call.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.

The arithmetic here is unusually easy to do, because ZipHealth publishes a price for every dose — and unusually easy to get wrong, because none of those prices includes the $79 clinical service and support fee. The FAQ says that fee applies to new and repeat patients, so it recurs. Cheapest genuine month: $149 + $79 = $228. Zepbound at 7.5mg and above: $449 + $79 = $528. What you get for it is the FDA-approved drug rather than a compounded version — there is no compounding here at all.

The insurance-and-brand heavyweight: a WeightWatchers-run membership that routes you toward FDA-approved product and insurance coverage, with a video visit required in some states — the membership fee and the medication bill are two separate charges.

GoodRx now runs a real prescriber, not just a coupon, and the two should not be confused. GoodRx Care Direct charges $39 a month for unlimited online care and bills the medication separately — read live on 2026-08-26, it lists the Wegovy pill as low as $149 a month, the Wegovy and Wegovy HD pens as low as $199 and the Zepbound KwikPen as low as $299, all under the label only FDA-approved medications, with no compounded tier at all. Every one of those is an as low as rather than a rate, so treat them as the bottom of a dose ladder. One thing here is better than almost anything else on this list for a working parent: GoodRx says a visit with a healthcare professional takes place via text, call or video, which means a text-only path exists. One thing is worse, and it belongs in the open. In February 2023 the Department of Justice, acting for the Federal Trade Commission, filed a complaint and a stipulated order in the Northern District of California, and GoodRx Holdings, Inc. agreed to a $1.5 million civil penalty over allegations that it shared users' prescription and health information with advertising platforms contrary to its own privacy promises; the order permanently bars it from disclosing user health information for advertising, and the case caption names GoodRx Care, the service reviewed here. That is a data question rather than a medicine question, and it is exactly the kind of thing worth knowing before you type your health history into a form.